Unibest 优贝德
← Back to patent-cliff list

CAS 3680-69-1

4-chloro-7H-pyrrolo[2,3-d]pyrimidine

CodesTOFA-003、RUXO-001

Application context (from source-drug indications)

强直性脊柱炎枸橼酸托法替布幼年型类风湿性关节炎枸橼酸托法替布溃疡性结肠炎枸橼酸托法替布银屑病关节炎枸橼酸托法替布类风湿关节炎枸橼酸托法替布特应性皮炎磷酸芦可替尼白癜风磷酸芦可替尼移植物抗宿主病磷酸芦可替尼骨髓纤维化磷酸芦可替尼真性红细胞增多症磷酸芦可替尼

Source drugs (routes using this intermediate)

DrugTierExpiry
枸橼酸托法替布Tofacitinib CitrateTier B — Position early2028
磷酸芦可替尼Ruxolitinib PhosphateTier A — Act now2028

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualifications
Unibest Nantong cGMP Site4-Chloropyrrolo[2,3-d]pyrimidine
Pharmaceutical Intermediates
询价询价询价

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.